https://www.taxtmi.com/news?id=65618 Appointment of SMT's CEO as Co-Chair of the FICCI Medical Devices Committee positions the company to engage in stakeholder consultations and influence sectoral priorities such as regulatory reform, import substitution, R&D promotion and trade policy. SMT also discloses that it has filed a draft red herring prospectus with securities regulators and exchanges for a proposed IPO, subject to approvals and market conditions, and cautions investors to consult the prospectus and its "Risk Factors" section. en-us Tue, 23 Dec 2025 16:31:03 +0530 Tue, 23 Dec 2025 16:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=65618 Appointment of SMT's CEO as Co-Chair of the FICCI Medical Devices Committee positions the company to engage in stakeholder consultations and influence sectoral priorities such as regulatory reform, import substitution, R&D promotion and trade policy. SMT also discloses that it has filed a draft red herring prospectus with securities regulators and exchanges for a proposed IPO, subject to approvals and market conditions, and cautions investors to consult the prospectus and its "Risk Factors" section. News - Tue, 23 Dec 2025 16:31:03 +0530 https://www.taxtmi.com/news?id=65618